In agreement with emerging evidence regarding the UCP1-independent role of beige fat18,19,36, fat-specific CUL2–APPBP2 blockade not only improved glucose intolerance, insulin resistance and lipid profile, but also suppressed WAT inflammation and fibrosis before changes in body weight. Here, CUL2 is linked to Insulin resistance.